Icon Cancer Centre - Singapore

17/06/2026

Lutetium-177 Prostate Specific Membrane Antigen (PSMA) therapy is a type of theranostics treatment for prostate cancer. It works by targeting the PSMA protein, which is typically found in higher amounts on prostate cancer cells, allowing treatment to be delivered directly to the cancer while minimising the impact on healthy tissue.

Learn how Lutetium-177 PSMA Therapy works below.

Lutetium-177 PSMA Therapy for advanced prostate cancer is now available at Icon Cancer Centre at Mount Alvernia. Please contact us at
E: [email protected]
T: (65) 6992 8649

15/06/2026

June marks Men’s Health Month, a reminder for men to prioritise their health.

The top 5 cancers affecting Singaporean men are prostate, colorectal, lung, lymphoid neoplasms and liver cancer. Many of these cancers such as prostate, colorectal and lung cancer can be treated more effectively when caught early through regular screening and healthy lifestyle choices.

Cancer screenings are available at Icon Health Screening. For more information, please contact:​
📞(65) 6970 5200 ​
📧[email protected] ​
💻https://tinyurl.com/mencancerstat

12/06/2026

Last weekend, Dr Karmen Wong (Medical Oncologist and Medical Director of Icon Cancer Centre Singapore) was invited to speak at the Jakarta Family Medicine Meeting 2026 comprising more than 200 family doctors in Indonesia.

During her presentation, Dr Wong discussed current approaches to cancer screening, as well as emerging advancements such as circulating tumour DNA (ctDNA) testing for early cancer detection. She also highlighted how innovations in cancer treatment are expanding options beyond traditional chemotherapy, including antibody-drug conjugates (ADCs) and targeted therapies.

Through these shared clinical experiences, we hope to raise greater cancer awareness among family doctors who are often the first point of contact for patients and strengthen early detection and screening, ultimately improving outcomes across Indonesia.

12/06/2026

Annie Nguyen (Regional Manager of Clinical Quality and Governance, Icon ASEAN) and Yvette James (Nurse Educator, Icon Australia) and recently represented Icon at Singapore’s inaugural Cancer Nurses Safety Advisory Board.

Bringing together nursing and pharmacy leaders from across Australia, India, Japan, Malaysia, Hong Kong, and Singapore, the forum focused on strengthening global standards in hazardous drug handling and chemotherapy exposure safety.

Their participation in the Cancer Nurses Safety Advisory Board reflects Icon’s commitment to advancing clinical excellence, strengthening safety standards, and supporting best practice in cancer care. By sharing their expertise and collaborating with healthcare leaders from across the region, they are helping drive important conversations that will shape safer outcomes for patients and healthcare professionals.

11/06/2026

Congratulations to Joline Chua (Principal Radiation Therapist) and Jong Wei Loong (Medical Physics Manager, Icon ASEAN), on presenting their poster at European Society for Radiotherapy and Oncology (ESTRO), held in Stockholm, Sweden.

Their poster showcased their experience using a specially designed radiotherapy bra that was used in surface-guided radiotherapy (SGRT) for breast cancer patients and how it is used to support more consistent positioning, treatment accuracy and patient comfort.

The conference also provided a valuable opportunity to connect with colleagues from Icon Group, Anthony Walsh (Group Director of Medical Physics) and Nola Bailey (Group Lead Radiation Therapist), reinforcing collaboration and shared learning across our organisation.

We are proud to see our iconic team contributing to international conversations on cancer care. By sharing real-world clinical experiences and outcomes, they help advance best practices and support innovation across the oncology community.

08/06/2026

This World Brain Tumour Day, we highlight how innovation in radiotherapy is helping support better care for patients facing multiple brain tumours.

HyperArc is evolving treatment for advanced secondary brain tumours, offering a non-surgical alternative that allows clinicians to treat up to 20 tumours within the brain and a greater volume of tumours compared to only one to two lesions using conventional techniques. It also eliminates the need to deliver whole brain radiation therapy treatment which comes with significant side effects.

Watch this video featuring Dr Choo Bok Ai (Radiation Oncologist) to learn more about this radiotherapy technique.

Contact us:
💻 https://tinyurl.com/wbtd-hyperarc
📩[email protected]
📱+65 8597 6128 (Whatsapp)

08/06/2026

Thank you to everyone who joined us for “Emerging Technologies in Breast Cancer: From AI to Personalised Therapy” on 6 June 2026.

With over 200 participants (in person and virtually), this scientific conference brought together a dynamic community of healthcare professionals committed to advancing breast cancer care.

From exploring advanced systemic management of HER2+ breast cancer to the integration of AI in mammography and stereotactic radiotherapy, the discussions reflected the strength of multidisciplinary collaboration in shaping the future of care.

We were also pleased to host an exclusive centre tour, offering attendees a closer look at our facilities and integrated approach to cancer care.

Our sincere appreciation to all the distinguished moderators, speakers from Indonesia and Singapore, participants and partners who made this second instalment of our Multidisciplinary Cancer Care Seminar Series a success. Your insights and dedication continue to drive meaningful progress in breast cancer care.

07/06/2026

Two years ago, cancer entered Tracy’s life in a way she never expected. Her world shifted overnight, there was fear and moments when she felt completely lost. But in the midst of it, she found her anchor, her young children. She knew she wanted to be there to watch them grow.

For them, she faced cancer with courage, leaning on the love and support of family and friends through the hardest days and the uncertainty.

Today, she stands as a reminder that with a positive mindset and courage, you can overcome even the toughest challenges.

05/06/2026

Today, we spotlight one of the latest treatments for nasopharyngeal carcinoma (NPC), a type of head and neck cancer.

Watch the video to hear Dr Patricia Kho (Medical Oncologist) explain how immunotherapy treatment works.

Dr Patricia Kho is a medical oncologist who specialises in breast, gastrointestinal, gynaecological, head and neck, and lung cancers. To read her profile, visit https://tinyurl.com/drkho-npctreatment

04/06/2026

Theranostics is a personalised form of cancer treatment that combines targeted therapy and diagnostic imaging to treat certain cancers. It aims to slow the growth and spread of cancer, relieve symptoms and maintain or improve quality of life.

Theranostics may be considered for people with advanced cancer, when standard treatment options are unsuitable or no longer effective and symptoms are affecting quality of life.

To learn how this form of treatment works, please visit https://tinyurl.com/whatistheranostics

Lutetium-177 PSMA therapy for prostate cancer is now available at Icon Cancer Centre at Mount Alvernia. Please contact us at:
📞 +65 6255 0528
📧 [email protected]

Theranostics is an advanced, personalised cancer treatment. It aims to slow the growth and spread of cancer, relieve symptoms and improve quality of life.